Skip to content

Deep Venous Thrombophlebitis

Deep Venous Thrombophlebitis (DVT), often simply called Deep Vein Thrombosis, is a condition in which a blood clot (thrombus) forms in one or more of the deep veins in the body, most commonly in the legs or pelvis. These deep veins are located deep within the muscles, unlike superficial veins just under the skin. The presence of a clot can obstruct blood flow, causing pain and swelling. DVT is a serious condition because the clot can break loose and travel through the bloodstream to the lungs, causing a pulmonary embolism (PE), which is a life-threatening medical emergency. Prompt diagnosis and treatment are crucial to prevent PE and other long-term complications.

Causes:

DVT typically occurs when there is a disruption in one or more components of Virchow’s Triad: venous stasis (slow blood flow), hypercoagulability (increased clotting tendency), or endothelial injury (damage to the blood vessel lining).

  • Venous Stasis (Slow Blood Flow):
    • Prolonged Immobility: Common during long periods of sitting (e.g., long flights, car rides), bed rest (e.g., after surgery or illness), or paralysis.
    • Major Surgery: Especially orthopedic surgeries of the hip or knee, abdominal surgery.
    • Hospitalization: Reduced mobility during illness or recovery.
    • Obesity.
    • Heart Failure: Reduced pumping efficiency can lead to slower blood flow in veins.
  • Hypercoagulability (Increased Clotting Tendency):
    • Inherited Thrombophilias: Genetic conditions that increase clotting risk (e.g., Factor V Leiden mutation, prothrombin gene mutation, deficiencies of antithrombin, Protein C, or Protein S).
    • Cancer: Many types of cancer increase clotting factors or damage blood vessels, raising DVT risk. Chemotherapy can also increase risk.
    • Pregnancy and Postpartum Period: Hormonal changes and increased pressure on pelvic veins. The risk is highest in the postpartum period.
    • Estrogen-Containing Medications: Oral contraceptives, hormone replacement therapy.
    • Antiphospholipid Syndrome (APS): An autoimmune disorder that directly increases clotting risk.
    • Inflammatory Bowel Disease (IBD): Chronic inflammation can contribute to hypercoagulability.
    • Sepsis/Severe Infection.
    • Dehydration.
  • Endothelial Injury (Damage to the Blood Vessel Lining):
    • Trauma: Direct injury to a vein.
    • Surgery: Especially orthopedic or abdominal surgery.
    • Previous DVT: Damaged vein walls from a prior clot increase the risk of recurrence.
    • Central Venous Catheters: Lines placed in large veins for medication or fluid administration can irritate the vein lining.
    • Varicose Veins: While superficial, severe varicose veins can sometimes be associated with DVT.

Symptoms:

DVT symptoms can vary. Some people experience no symptoms, especially if the clot is small. When symptoms occur, they usually affect the limb where the clot has formed.

  • Swelling: In the affected limb (leg, ankle, or foot), often unilateral (one-sided). The swelling may be pitting (indentation remains after pressing).
  • Pain or Tenderness: In the affected limb, often described as a cramp or soreness, or a deep ache. May worsen with walking or standing.
  • Warmth: In the skin over the affected area.
  • Redness or Discoloration: Of the skin over the affected area.
  • Visible Veins: Swelling of superficial veins.
  • Increased Leg Circumference: Compared to the unaffected leg.
  • Symptoms of Pulmonary Embolism (PE) – Medical Emergency: If a DVT travels to the lungs.
    • Sudden shortness of breath.
    • Chest pain (sharp, stabbing, often worse with deep breath or cough).
    • Rapid heart rate.
    • Unexplained cough (may be bloody).
    • Dizziness or lightheadedness, fainting.
    • Anxiety.

Diagnosis:

Diagnosing DVT requires prompt evaluation to confirm the presence of a clot and initiate appropriate treatment. It primarily involves imaging tests.

  • Medical History and Physical Exam: The doctor will ask about symptoms, risk factors for DVT, and family history. The exam involves checking for swelling, tenderness, warmth, and skin changes in the affected limb.
  • D-dimer Blood Test:
    • A blood test that measures a substance released when a blood clot dissolves.
    • A negative D-dimer test can often rule out DVT in low-risk patients (high sensitivity).
    • However, a positive D-dimer can indicate a clot but can also be elevated in many other conditions (e.g., infection, surgery, pregnancy, cancer), so it’s not specific for DVT.
  • Duplex Ultrasound (Venous Ultrasound):
    • The most common and effective diagnostic test for DVT.
    • Uses sound waves to visualize blood flow in the veins and detect blockages (clots). The inability to compress a vein with ultrasound probe pressure is a key sign of a clot.
  • CT Venography or MR Venography:
    • More detailed imaging tests used when ultrasound is inconclusive or if clots are suspected in veins in the abdomen or pelvis.
    • Involve injecting contrast dye to highlight the veins.
  • Venography: (Less common) An invasive X-ray test using contrast dye injected directly into a vein. Considered the gold standard but rarely used now due to less invasive methods.

Treatment:

Treatment for DVT aims to prevent the clot from growing, prevent it from breaking off and causing a pulmonary embolism, and reduce the risk of future clots and long-term complications (post-thrombotic syndrome). Anticoagulant medications are the cornerstone of treatment.

  • Anticoagulant Medications (Blood Thinners):
    • These medications do not dissolve existing clots but prevent new clots from forming and stop existing clots from growing larger, allowing the body’s natural clot-dissolving mechanisms to work.
    • Initial Treatment (typically 5-10 days):
      • Low Molecular Weight Heparin (LMWH) Injections: (e.g., enoxaparin) or unfractionated heparin (IV for severe cases).
      • Direct Oral Anticoagulants (DOACs) or Factor Xa Inhibitors: (e.g., rivaroxaban – Xarelto, apixaban – Eliquis, edoxaban – Savaysa, dabigatran – Pradaxa) Can sometimes be started immediately without initial heparin.
    • Long-Term Treatment (typically 3-6 months or longer):
      • Warfarin (Coumadin): Requires regular INR blood monitoring.
      • DOACs: Increasingly preferred due to convenience and no need for routine monitoring.
    • The duration of anticoagulation depends on whether the DVT was provoked (e.g., by surgery, trauma) or unprovoked, and the presence of underlying thrombophilias.
  • Thrombolysis (Clot-Busting Drugs):
    • (Rarely used) Medications that actively dissolve blood clots.
    • Reserved for very severe DVTs (e.g., involving large veins, causing limb-threatening ischemia) or large PEs, due to a high risk of bleeding.
    • Can be given systemically (IV) or catheter-directed (delivered directly to the clot).
  • Inferior Vena Cava (IVC) Filter:
    • A small filter placed in the large vein in the abdomen (inferior vena cava) to catch blood clots traveling from the legs to the lungs.
    • Used for patients who cannot take anticoagulants (due to bleeding risk) or who develop recurrent PEs despite anticoagulation.
    • Many are now retrievable.
  • Compression Stockings:
    • Graduated compression stockings can help reduce leg swelling and prevent or alleviate symptoms of post-thrombotic syndrome (PTS), a long-term complication of DVT.
  • Lifestyle Modifications and Risk Factor Management:
    • Early Ambulation: Get up and move as soon as possible after surgery or illness.
    • Regular Exercise: To improve blood flow.
    • Maintain a Healthy Weight.
    • Quit Smoking.
    • Stay Hydrated.
    • Avoid Prolonged Immobility: During long travel, take breaks to walk around, stretch legs, or wear compression stockings.
    • Manage Underlying Conditions: (e.g., cancer, autoimmune diseases).

Long-term management of DVT requires ongoing communication with a healthcare provider, often a hematologist or vascular specialist, to manage anticoagulation and monitor for complications.